[1]
V. C. Sangar, B. B. Ghongane, and A. Chowdhary, “POST-MARKETING PASSIVE SURVEILLANCE OFBIVALENT AND QUADRIVALENT HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINES”, Int J Pharm Pharm Sci, vol. 7, no. 4, pp. 393–397, Apr. 2015.